Literature DB >> 16476887

Iris pigment epithelial translocation in the treatment of exudative macular degeneration: a 3-year follow-up.

Sabine Aisenbrey1, Bart A Lafaut, Peter Szurman, Ralph-Dieter Hilgers, Peter Esser, Peter Walter, Karl U Bartz-Schmidt, Gabriele Thumann.   

Abstract

OBJECTIVE: To report the functional and anatomical outcome of 20 patients who underwent surgical removal of choroidal neovascularization combined with transplantation of autologous iris pigment epithelial cells to the subretinal space 3 years after treatment.
METHODS: Freshly isolated autologous iris pigment epithelial cells were translocated to the subretinal space in 20 patients after membrane extraction. Patients were followed up by funduscopy, angiography, microperimetry, and visual acuity testing.
RESULTS: After a follow-up of 3 years, 1 patient showed improved visual acuity, 13 patients retained stable visual acuity, and 3 patients had reduced visual acuity. No macular edema or recurrent choroidal neovascularization was apparent at any time during the follow-up.
CONCLUSIONS: Transplanted autologous iris pigment epithelial cells were well tolerated for 3 years and stabilization of visual acuity was achieved in most patients. These results suggest that iris pigment epithelial cells may serve as a substitute for retinal pigment epithelial cells after choroidal neovascularization removal in patients with exudative macular degeneration; however, whether these cells will be of any value for the restoration of vision and possible protection against choroidal neovascularization recurrence awaits further clinical observation and additional research.

Entities:  

Mesh:

Year:  2006        PMID: 16476887     DOI: 10.1001/archopht.124.2.183

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

Review 1.  Cell replacement and visual restoration by retinal sheet transplants.

Authors:  Magdalene J Seiler; Robert B Aramant
Journal:  Prog Retin Eye Res       Date:  2012-07-05       Impact factor: 21.198

Review 2.  Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration.

Authors:  Hongjun Du; Siok Lam Lim; Seanna Grob; Kang Zhang
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

3.  Transplantation of rat embryonic stem cell-derived retinal cells restores visual function in the Royal College of Surgeons rats.

Authors:  Hongxi Wu; Jia Li; Xinbang Mao; Guodong Li; Lin Xie; Zhipeng You
Journal:  Doc Ophthalmol       Date:  2018-08-03       Impact factor: 2.379

4.  Age-related macular degeneration: current treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

5.  Preservation of photoreceptors in dystrophic RCS rats following allo- and xenotransplantation of IPE cells.

Authors:  Gabriele Thumann; Anna Katharina Salz; Peter Walter; Sandra Johnen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

6.  In situ regeneration of retinal pigment epithelium by gene transfer of E2F2: a potential strategy for treatment of macular degenerations.

Authors:  D Kampik; M Basche; U F O Luhmann; K M Nishiguchi; J A E Williams; J Greenwood; S E Moss; H Han; S Azam; Y Duran; S J Robbie; J W B Bainbridge; D F Larkin; A J Smith; R R Ali
Journal:  Gene Ther       Date:  2017-11-30       Impact factor: 5.250

Review 7.  Ophthalmic transplantology: posterior segment of the eye--part II.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Wanda Romaniuk; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2012-06

Review 8.  Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.

Authors:  P Fernández-Robredo; A Sancho; S Johnen; S Recalde; N Gama; G Thumann; J Groll; A García-Layana
Journal:  J Ophthalmol       Date:  2014-01-14       Impact factor: 1.909

Review 9.  Ocular stem cells: a status update!

Authors:  Kamesh Dhamodaran; Murali Subramani; Murugeswari Ponnalagu; Reshma Shetty; Debashish Das
Journal:  Stem Cell Res Ther       Date:  2014       Impact factor: 6.832

10.  Prospectives for gene therapy of retinal degenerations.

Authors:  Gabriele Thumann
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.